Stemtech Revenue Growth Rates (STEK), Current and Historic Growth - CSIMarket
CSIMarket
 


Stemtech Corporation  (STEK)
 

STEK's Revenue Growth by Quarter and Year

Stemtech's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/STEK/growth
https://api.csimarket.com/api/v1/companies/STEK/fundamentals
https://api.csimarket.com/api/v1/companies/STEK/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
STEK Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 0.28
2nd Quarter June 0.63
1st Quarter March 0.46
FY 1.37

STEKs Annual Revenue
Stemtech's Revenue in the fiscal year 2025 $ 2.88 millions
Stemtech's Revenue in the fiscal year 2024 $ 4.73 millions
Stemtech's Revenue in the fiscal year 2023 $ 4.92 millions
Stemtech's Revenue in the fiscal year 2022 $ 4.50 millions
Stemtech's Revenue in the fiscal year 2021 $ 5.33 millions




STEK Revenue third quarter 2026 Y/Y Growth Comment
Stemtech Corporation reported drop in Revenue in the third quarter 2026 by -66.77% to $ 0.28 millions, from the same quarter in 2025.
The fall in the third quarter 2026 Stemtech Corporation's Revenue compares unfavorably to the Company's average Revenue decrease of -4.61%.

Looking into third quarter 2026 results within Pharmacy Services & Retail Drugstore industry 7 other companies have achieved higher Revenue growth. While Stemtech Corporation' s Revenue meltdown of -66.77% ranks overall at the positon no. 3632 in the third quarter 2026.




STEK Revenue ( Y/Y Growth %) 2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -66.77 %
2nd Quarter June -10 %
1st Quarter March -47.13 %
FY   -

Financial Statements
Stemtech's third quarter 2026 Revenue $ 0.28 millions STEK's Income Statement
Stemtech's third quarter 2025 Revenue $ 0.85 millions Quarterly STEK's Income Statement


STEK Revenue (Quarter on Quarter Growth %)

2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -55.16 %
2nd Quarter June 36.96 %
1st Quarter March 0 %
FY (Year on Year)   -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #8
Retail Sector #167
Overall #3632

Revenue Y/Y Growth Statistics
High Average Low
237.31 % -4.61 % -90.79 %
(Jun 30 2024)   (Jun 30 2023)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #8
Retail Sector #167
Overall #3632
Revenue Y/Y Growth Statistics
High Average Low
237.31 % -4.61 % -90.79 %
(Jun 30 2024)   (Jun 30 2023)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Stemtech's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
387.38 % 20.87 % -68.3 %
(Dec 31 2021)  


STEK's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Stemtech Corporation disclosed fall in Revenue from the second quarter by -55.16% to $ 0.28 millions, from $ 0.63 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2026 Revenue, this plainly could not be substantial to rescue Pharmacy Services & Retail Drugstore's company achievement, Most analysts pointed out.

Within Pharmacy Services & Retail Drugstore industry Stemtech Corporation achieved highest sequential Revenue growth. While Stemtech's Revenue growth quarter on quarter, overall rank is 485.


Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #1
Retail Sector #28
Overall #485
Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #1
Retail Sector #28
Overall #485
Revenue Q/Q Growth Statistics
High Average Low
387.38 % 20.87 % -68.3 %
(Dec 31 2021)  


STEK's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Stemtech Corporation disclosed fall in Revenue from the second quarter by -55.16% to $ 0.28 millions, from $ 0.63 millions achived in the previous reporting period.

Although periodic circumstance commonly energize III. Quarter 2026 Revenue, this plainly could not be substantial to rescue Pharmacy Services & Retail Drugstore's company achievement, Most analysts pointed out.

Within Pharmacy Services & Retail Drugstore industry Stemtech Corporation achieved highest sequential Revenue growth. While Stemtech's Revenue growth quarter on quarter, overall rank is 485.


Stemtech's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)
12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 2.40
Y / Y Revenue Growth (TTM) -38.57 %
Year on Year Revenue Growth Overall Ranking # 4191
Seqeuential Revenue Change (TTM) -2.78 %
Seq. Revenue Growth (TTM) Overall Ranking # 3929


Cumulative Revenue growth Comment
Stemtech showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Stemtech's annual Revenue decline would be -38.57% year on year to $2 millions.

In the Retail sector 198 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 575 to 4191.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 9
Retail Sector # 199
Overall # 4191

Revenue TTM Y/Y Growth Statistics
High Average Low
46.12 %
-14.85 %
-56.13 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 189
S&P 500 # 3929
Cumulative Revenue growth Comment
Stemtech showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Stemtech's annual Revenue drop would be -38.57% year on year to $2 millions.

In the Retail sector 198 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 575 to 4191.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 9
Retail Sector # 199
Overall # 4191

Revenue TTM Y/Y Growth Statistics
High Average Low
46.12 %
-14.85 %
-56.13 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 189
S&P 500 # 3929




Other Revenue Growth
Pharmacy Services & Retail Drugstore Industry Revenue Growth Trends and Statistics
Retail Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
STEK's Revenue Growth Ratio versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Sep 30 2026 within Retail SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Albertsons Companies Inc -0.11%$ -0.110 millions
Autonation Inc -0.39%$ -0.385 millions
Grabagun Digital Holdings Inc -0.70%$ -0.702 millions
Guardian Pharmacy Services Inc -1.68%$ -1.684 millions
Builders Firstsource Inc -2.19%$ -2.194 millions
Hour Loop Inc -3.32%$ -3.316 millions
Growgeneration Corp -4.42%$ -4.424 millions
Group 1 Automotive Inc-6.68%$ -6.675 millions
Asbury Automotive Group Inc -8.07%$ -8.067 millions
The Honest Company Inc -8.52%$ -8.516 millions
Camping World Holdings Inc -12.36%$ -12.358 millions
Nu Skin Enterprises Inc -14.49%$ -14.493 millions
Grove Collaborative Holdings Inc -15.81%$ -15.807 millions
Petmed Express Inc -17.61%$ -17.609 millions
Bark Inc -18.13%$ -18.135 millions
Latch Inc -18.86%$ -18.857 millions
Lulu s Fashion Lounge Holdings Inc -20.12%$ -20.117 millions
1 800 Flowers Com Inc-20.21%$ -20.214 millions
The Beachbody Company Inc -24.25%$ -24.249 millions
Monro Inc -40.25%$ -40.251 millions
Weis Markets inc-41.22%$ -41.216 millions
Crown Equity Holdings Inc -63.44%$ -63.441 millions
Hwh International Inc -64.87%$ -64.868 millions
Stemtech Corporation-66.86%$ -66.856 millions
Vroom Inc -96.18%$ -96.179 millions


About Stemtech Revenue Growth Rates (STEK), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Stemtech Corp (CIK 1511820).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001683168-26-008696
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Stemtech Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.